The Similac lawsuit in 2026 is one of the largest ongoing baby product injury litigations in U.S. history, with thousands of families seeking compensation after premature infants developed a life-threatening intestinal disease called necrotizing enterocolitis (NEC). If your baby was born prematurely and fed Similac or a similar cow’s milk-based formula in the NICU, you may have a valid legal claim right now.
This is not a small consumer refund case. Families have reported surgical procedures, permanent intestinal damage, and deaths linked to NEC. The stakes are extraordinarily high.
This article covers everything about the Similac lawsuit in 2026, including the current MDL status, payout ranges, who qualifies, what documents you need, and the filing deadline you cannot afford to miss.
Similac Lawsuit 2026: Where Things Stand Right Now
The Similac lawsuit in 2026 remains active in federal court, with thousands of individual cases consolidated in the Northern District of Illinois under MDL No. 3026. Progress has been slow but steady.
Several bellwether trials, which are early test cases that signal how juries will respond to the evidence, have produced significant results favoring plaintiffs in recent years. Those outcomes have pushed settlement conversations into a more serious phase heading into 2026.
Abbott Laboratories has continued to contest liability. The company argues that its products met FDA standards and that NEC is a condition tied to prematurity itself, not formula. Plaintiffs counter that Abbott knew the elevated risk and failed to warn NICU staff and parents adequately.
| Key 2026 Litigation Details | Information |
|---|---|
| Court | Northern District of Illinois |
| MDL Number | MDL No. 3026 |
| Presiding Judge | Hon. Rebecca R. Pallmeyer |
| Defendants | Abbott Laboratories, Mead Johnson Nutrition |
| Primary Injury Claimed | Necrotizing Enterocolitis (NEC) |
| Number of Cases (approx.) | 1,000+ consolidated cases |
| Current Phase | Bellwether trials and settlement discussions |
The number of active cases continues to grow as more families learn about the litigation. If you have not filed yet, you are not too late, but the window is narrowing.
Similac Lawsuit Update 2026: What Has Changed This Year
The biggest shift heading into 2026 is the increasing pressure on Abbott to reach a global settlement. Multiple bellwether trial results from 2023 through 2025 showed that juries are receptive to plaintiff arguments, including multi-million dollar verdicts in some cases.
Plaintiffs’ leadership committees have been in ongoing discussions with defense counsel about a potential global resolution. No confirmed settlement fund has been announced as of early 2026, but legal observers expect movement by mid-year.
The courts have also tightened scheduling orders, meaning cases that were once backlogged are now moving toward trial dates. This is significant for claimants still waiting for their day in court.
Key 2026 development: Courts have indicated that cases filed without complete medical documentation may face dismissal, making proper claim preparation more important than ever this year.
- Bellwether verdicts from prior years continue to shape settlement value estimates
- Abbott’s legal defense strategy has shifted slightly toward challenging causation evidence
- New plaintiff law firms have entered the litigation, increasing filing volume
- Courts are enforcing stricter documentation requirements for 2026 filings
Think of it like a long line at a government office. The people at the front got there first, their cases are nearly resolved. The people who just arrived need to make sure their paperwork is complete or they will get sent to the back.
What Is the Similac NEC Lawsuit
The Similac NEC lawsuit refers to product liability claims filed by families of premature infants who developed necrotizing enterocolitis after being fed Similac cow’s milk-based formula in hospital NICUs. NEC is a devastating gastrointestinal condition that destroys intestinal tissue.
The lawsuits allege that Abbott Laboratories, the maker of Similac, knew that cow’s milk-based formulas significantly increased the risk of NEC in premature infants. Plaintiffs claim Abbott failed to include adequate warnings on its products and marketing materials.
Research published in respected medical journals has shown that premature infants fed cow’s milk-based formula face a substantially higher risk of developing NEC compared to those fed human breast milk or donor milk. The American Academy of Pediatrics has issued guidance supporting breast milk use for premature infants specifically because of this risk.
| Lawsuit Component | Detail |
|---|---|
| Product at Issue | Similac cow’s milk-based NICU formulas |
| Manufacturer | Abbott Laboratories |
| Alleged Harm | Necrotizing enterocolitis (NEC) |
| Legal Theory | Product liability, failure to warn |
| Who Can Sue | Families of premature infants with NEC diagnosis |
The legal argument is not that Similac caused every case of NEC. It is that Abbott should have warned parents and medical professionals about the elevated risk specific to premature infants.
Abbott Laboratories NEC Lawsuit Status
Abbott Laboratories is defending against thousands of NEC-related lawsuits filed in federal court. The company has not settled the MDL collectively as of early 2026, but individual case resolutions have occurred quietly in some instances.
Abbott’s legal strategy has focused on three main defenses. First, the company argues that NEC occurs naturally in premature infants regardless of formula use. Second, it claims that FDA-approved labeling met all required disclosure standards. Third, it challenges the scientific causation evidence presented by plaintiffs’ expert witnesses.
Despite those defenses, Abbott has faced significant courtroom setbacks. Trial courts in Missouri and Illinois ruled in favor of plaintiff families in several early cases, with jury awards reaching into the millions. Those outcomes have real influence on how the MDL proceeds.
Abbott’s financial exposure is substantial. Legal analysts following the case have noted that if Abbott loses a significant number of trials, the financial pressure could force a global settlement fund similar to what has been seen in other mass tort litigations like the talcum powder and opioid cases.
The company continues to sell its infant formula products while the litigation proceeds. Abbott has not issued a voluntary recall of the products at the center of the lawsuit.
Key Takeaway: The Similac lawsuit in 2026 is an active federal MDL with real courtroom results favoring plaintiffs, growing case volume, and increasing pressure on Abbott for a global settlement.
Similac Baby Formula Lawsuit Overview
The Similac baby formula lawsuit covers products specifically designed and marketed for use in hospital NICUs with premature infants. The most frequently named products include Similac Special Care and Similac Human Milk Fortifier.
These are not the standard grocery store versions of Similac. The NICU-specific formulas are highly concentrated, cow’s milk-based products given to infants who are often born weeks or months before their due date. Premature infants have underdeveloped digestive systems that may react differently to cow’s milk proteins.
The lawsuit is not about formula generally. It targets specific products, used in specific settings, for a specific vulnerable population. That distinction matters for eligibility.
| Product Name | Use Setting | Risk Factor |
|---|---|---|
| Similac Special Care | NICU | High, for premature infants |
| Similac Human Milk Fortifier | NICU (added to breast milk) | High, contains cow’s milk proteins |
| Similac Advance (standard) | Home use | Lower, not primary subject of lawsuit |
| Enfamil Premature (Mead Johnson) | NICU | Also named in related MDL claims |
If your baby received formula in a NICU setting and later developed NEC, the specific brand and type of formula used is a central factor in determining whether you have a valid claim.
Similac and Necrotizing Enterocolitis: The Medical Connection
Necrotizing enterocolitis is a severe intestinal condition where tissue in the intestines dies, sometimes causing the intestinal wall to perforate. It is one of the leading causes of death among premature infants in NICUs across the United States.
Studies published in journals including the Journal of Pediatrics and Pediatrics have found that premature infants fed cow’s milk-based formula are significantly more likely to develop NEC than those fed human breast milk. Some research has suggested the risk increase ranges from 6 to 10 times higher depending on gestational age and formula type.
The biological explanation centers on how premature gut tissue responds to cow’s milk proteins. A premature baby’s intestines are not fully developed. When they encounter cow’s milk-based formula, inflammatory responses can damage the intestinal lining. In some infants, this leads to NEC within days of feeding.
- NEC affects approximately 1 in 1,000 live births overall
- The condition is far more common in premature infants, affecting up to 10% of babies born before 28 weeks gestation
- NEC carries a mortality rate of 15% to 30% in severe cases
- Survivors may face lifelong complications including short bowel syndrome
The medical link between cow’s milk-based NICU formula and NEC is the backbone of every plaintiff’s case. Without it, the lawsuit would not exist.
Who Qualifies for the Similac Lawsuit
You may qualify for the Similac lawsuit if your premature infant was fed Similac or another cow’s milk-based NICU formula and was subsequently diagnosed with necrotizing enterocolitis. This is the core eligibility framework.
Both wrongful death claims and personal injury claims are available. If your baby survived NEC but suffered surgical complications, intestinal damage, or long-term health effects, you may file a personal injury claim. If your baby passed away as a result of NEC, a wrongful death claim may be available to the family.
The child does not need to have been exclusively formula-fed. Even partial use of cow’s milk-based formula in the NICU alongside breast milk feeding may be sufficient to establish a valid claim depending on the specific facts.
| Qualifying Factor | Requirement |
|---|---|
| Infant status at time of feeding | Premature birth (typically born before 37 weeks gestation) |
| Formula used | Similac or cow’s milk-based NICU formula (any brand named in MDL) |
| Diagnosis | Necrotizing enterocolitis (NEC) |
| Timing | NEC diagnosis must follow formula feeding |
| Claim types available | Personal injury or wrongful death |
Not every NEC case qualifies automatically. The connection between formula feeding and the NEC diagnosis needs to be documentable through medical records.
Key Takeaway: To qualify for the Similac lawsuit, a premature infant must have received cow’s milk-based NICU formula and then been diagnosed with NEC, with medical records supporting both facts.
Similac Lawsuit Eligibility Requirements
Eligibility for the Similac lawsuit in 2026 depends on four core factors: prematurity of the infant, use of a qualifying formula product, NEC diagnosis, and causal timing between the feeding and the diagnosis.
Let’s break each one down.
Prematurity: Most cases involve infants born before 37 weeks gestation. Infants born before 28 weeks gestation are considered to be at the highest risk and are the most common claimants.
Formula use: The infant must have been fed a cow’s milk-based formula in a NICU setting. This includes Similac Special Care, Similac Human Milk Fortifier, Enfamil Premature, and similar NICU-specific products from other manufacturers who are co-defendants in the MDL.
NEC diagnosis: The infant must have a documented medical diagnosis of NEC. The relevant ICD-10 code is P77 (necrotizing enterocolitis of newborn). This must appear in the child’s medical records.
Causal timing: The NEC diagnosis must have followed formula feeding. Cases where NEC developed before any formula was introduced are typically not eligible.
- Born before 37 weeks gestation
- Fed Similac or qualifying cow’s milk-based NICU formula
- Diagnosed with NEC (ICD-10 code P77 or similar)
- NEC developed after formula feeding began
- Parent or legal guardian is able to file on behalf of the infant
Families who meet all four criteria are encouraged to consult with a mass tort attorney to evaluate the strength of their specific case.
Similac Lawsuit Premature Baby Claims
Claims filed on behalf of premature babies represent the overwhelming majority of the Similac lawsuit cases. Premature infants, especially those born significantly early, are the population most directly harmed by the alleged failure to warn.
The severity of NEC cases among claimants varies widely. Some infants required surgical removal of damaged intestinal tissue, a procedure called a bowel resection. Others underwent ostomy procedures. The most severe cases resulted in short bowel syndrome, a permanent condition affecting nutrient absorption for life.
Wrongful death claims are a painful but real part of this litigation. Families who lost premature infants to NEC are among those seeking justice through the courts. These cases often carry the highest potential compensation values because they involve the most severe irreversible harm.
| Injury Severity Level | Description | Claim Type |
|---|---|---|
| Mild NEC | Managed medically, no surgery | Personal injury |
| Moderate NEC | Hospitalization extended, some surgical intervention | Personal injury |
| Severe NEC | Bowel resection, ostomy, long-term complications | Personal injury (higher value) |
| Fatal NEC | Infant death caused by NEC | Wrongful death |
Premature baby claims require detailed NICU records showing gestational age, formula feeding logs, NEC diagnosis, and treatment records. The stronger and more complete those records are, the stronger the claim tends to be.
Similac Lawsuit Settlement Amount 2026
No confirmed global settlement amount has been announced in the Similac lawsuit as of early 2026. However, individual case resolutions and bellwether trial verdicts provide a reasonable framework for understanding what compensation may look like.
Jury verdicts in early bellwether trials have ranged from several hundred thousand dollars to over ten million dollars depending on the severity of the injury, the quality of the evidence, and the specific circumstances of each case. These verdicts are not the same as what every claimant will receive, but they set the tone for negotiations.
In mass tort litigations of this scale, a global settlement fund is typically negotiated based on the aggregate results of bellwether trials and the overall volume of claims. Individual payouts from such a fund are then allocated based on injury severity tiers.
| Estimated Compensation Tier | Injury Category | Estimated Range |
|---|---|---|
| Tier 1 | Mild NEC, no surgery, full recovery | $50,000 to $250,000 |
| Tier 2 | Moderate NEC, some surgical intervention | $250,000 to $1,000,000 |
| Tier 3 | Severe NEC, permanent complications | $1,000,000 to $5,000,000+ |
| Tier 4 | Wrongful death (infant died from NEC) | $2,000,000 to $10,000,000+ |
These figures are estimates based on bellwether results and comparable mass tort settlements. Final amounts depend on individual case specifics, attorney negotiations, and the terms of any global resolution.
Key Takeaway: Similac lawsuit settlement amounts in 2026 are not yet officially set, but prior jury verdicts and mass tort precedent suggest compensation could range from tens of thousands to millions of dollars depending on injury severity.
How Much Is the Similac Lawsuit Payout
The Similac lawsuit payout amount varies significantly based on the severity of the infant’s NEC injury and the strength of the available evidence. This is not a flat-rate consumer refund.
Factors that influence the final payout amount include the extent of medical treatment required, whether the infant survived, the long-term medical costs associated with NEC complications, and the emotional and financial impact on the family.
Cases involving wrongful death consistently produce the highest verdicts and settlement values in mass tort litigations. Cases involving permanent injury like short bowel syndrome also command substantial compensation because of the lifetime medical care involved.
- Documented medical expenses: NICU stays, surgeries, follow-up care
- Future medical costs: Ongoing treatment for NEC survivors
- Pain and suffering: Compensation for the infant’s and family’s experience
- Lost earning potential: Applicable in serious cases involving permanent disability
- Wrongful death damages: Loss of companionship, funeral costs, parental grief
Attorney fees in mass tort cases are typically taken on a contingency basis, meaning the family pays nothing upfront. Attorneys usually receive 33% to 40% of the final settlement or verdict as their fee.
If you are comparing the Similac lawsuit to other mass torts, the NEC baby formula litigation is more similar to pharmaceutical injury cases than to standard consumer class actions. The injuries are catastrophic, the defendants are large corporations, and the legal fees reflect that.
Similac Class Action vs Mass Tort: What Is the Difference
The Similac lawsuit is a mass tort, not a traditional class action. That distinction matters a great deal for claimants.
In a class action, all plaintiffs share one lawsuit and receive roughly equal, usually small, payouts from a common fund. Think of the typical “you get $15 back on your phone bill” type of settlement.
In a mass tort, each plaintiff files an individual lawsuit. All those cases are consolidated for pretrial proceedings to make the process more efficient, but each case is evaluated and resolved based on its individual facts and injury severity. That is why NEC claimants in serious cases can receive millions while others with milder injuries receive less.
| Feature | Class Action | Mass Tort (MDL) |
|---|---|---|
| Filing type | One shared lawsuit | Individual lawsuits consolidated |
| Payout structure | Equal or near-equal shares | Based on individual injury severity |
| Typical payout range | Small (often under $1,000) | Large (often $50,000 to millions) |
| Court type | State or federal | Federal MDL court |
| Similac lawsuit type | No | Yes, MDL No. 3026 |
The Similac litigation is formally called a Multidistrict Litigation, or MDL. All the individual cases are centralized in the Northern District of Illinois for efficiency, but each family’s claim stands on its own. Your payout is tied to your baby’s specific situation.
Similac MDL Status 2026
The Similac MDL, formally captioned In Re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation, is docketed as MDL No. 3026 in the Northern District of Illinois. The Honorable Rebecca R. Pallmeyer is presiding.
As of 2026, the MDL has progressed through the bellwether trial selection and early trial phase. Bellwether trials are test cases selected by the court to represent a range of claim types. The results guide both sides toward a realistic assessment of the litigation’s overall value.
Several bellwether trials have concluded with plaintiff-favorable outcomes, including jury awards in the multi-million dollar range. These outcomes have created meaningful pressure on Abbott and co-defendant Mead Johnson to explore broader settlement negotiations.
The MDL process typically follows a predictable arc. After enough bellwether trials produce consistent outcomes, the parties enter mediated settlement talks. If a global agreement is reached, a settlement fund is established and individual claims are processed through a claims administrator.
| MDL Phase | Status in 2026 |
|---|---|
| Consolidation | Completed |
| Discovery | Substantially complete |
| Bellwether trial selection | Completed |
| Bellwether trials | Ongoing, multiple completed |
| Global settlement discussions | In progress |
| Estimated global resolution | Potentially mid to late 2026 |
No official resolution date has been confirmed. The pace of settlement talks in 2026 is being closely watched by legal professionals and plaintiffs’ families alike.
How to File a Similac Lawsuit Claim
Filing a Similac lawsuit claim in 2026 starts with retaining a mass tort attorney who handles baby formula NEC cases. This is not a claim you file on a government website or through a simple online form.
The process works like this. You contact a mass tort law firm. They evaluate your case during a free consultation. If your child’s situation meets the eligibility criteria, the firm files an individual lawsuit on your behalf in the MDL. From that point, your case is part of the centralized litigation.
Because this is a contingency-fee arrangement, you pay nothing unless you win. The attorney takes their fee from the final settlement or verdict amount. There are no upfront costs for qualifying families.
| Step | What Happens |
|---|---|
| Step 1 | Contact a mass tort law firm for a free consultation |
| Step 2 | Share basic case details (birth records, NEC diagnosis, formula used) |
| Step 3 | Attorney evaluates eligibility and strength of claim |
| Step 4 | Law firm gathers full medical and hospital records |
| Step 5 | Individual lawsuit filed in the Northern District of Illinois MDL |
| Step 6 | Case processed through MDL pretrial proceedings |
| Step 7 | Case resolved through settlement or trial |
The most common mistake families make is waiting too long. Statutes of limitations apply, and in 2026, some older potential claims may already be expiring depending on the state where the injury occurred.
Key Takeaway: Filing a Similac lawsuit claim in 2026 requires working with a mass tort law firm. The process is free upfront, and cases are filed individually within the existing MDL in Illinois.
What Documents Do You Need for the Similac Lawsuit
Strong documentation is the difference between a viable claim and one that gets dismissed or receives a minimal settlement. Courts in 2026 are enforcing stricter documentation standards than in earlier years of this litigation.
The most critical document is the infant’s NICU medical record showing both formula feeding and the NEC diagnosis. This is non-negotiable. Without it, the causal link between the product and the injury cannot be established.
Families should also gather the infant’s birth records confirming premature birth, any surgical records related to NEC treatment, follow-up pediatric records, and any available documentation of the specific formula brand and product used during the NICU stay.
| Document Type | Why It Matters |
|---|---|
| NICU admission and discharge records | Shows prematurity, formula feeding history, and NEC diagnosis |
| Formula feeding logs (NICU) | Identifies specific Similac or cow’s milk product used |
| NEC diagnosis records | Confirms ICD-10 code P77 in the medical file |
| Surgical records | Documents severity of NEC and procedures performed |
| Follow-up pediatric records | Supports ongoing harm and long-term impact claims |
| Birth certificate or birth hospital records | Confirms gestational age at birth |
| Prescription or product purchase records | Supplemental support if available |
If you are worried that some records may be lost or incomplete, do not assume the worst. Mass tort attorneys are experienced in working with hospitals and medical systems to recover historical NICU records.
Hospitals are legally required to retain medical records for a minimum period under state laws. In many states, pediatric records must be kept for several years past the child’s 18th birthday. Records may still be available even for infants born years ago.
Similac Lawsuit Filing Deadline 2026
The filing deadline for the Similac lawsuit depends on the statute of limitations in the state where the injury occurred. This is not a single national deadline that applies to everyone.
Most states have a product liability statute of limitations ranging from two to four years from the date of injury or from the date a family reasonably discovered the connection between the formula and NEC. Some states apply the “discovery rule,” which extends the deadline to when the family knew or should have known about the potential legal claim.
This distinction matters enormously. A family whose child developed NEC in 2021 may still have a valid claim in 2026 in some states if they only recently learned about the litigation. In other states, that same claim may be approaching or past the filing window.
| State Example | Statute of Limitations | Notes |
|---|---|---|
| Illinois | 2 years from discovery | Discovery rule may extend deadline |
| California | 2 years from injury or discovery | Strong discovery rule protections |
| Texas | 2 years from injury | Strict deadline, fewer extensions |
| Florida | 4 years from injury | More generous window |
| New York | 3 years from injury | Discovery rule applied in some cases |
The only way to know for certain whether your claim is still within the statute of limitations is to speak with a mass tort attorney who can evaluate the specific facts and state law that applies to your family.
Do not assume you have missed the deadline without checking. Families who waited and assumed their window had closed have sometimes discovered that the discovery rule kept their claims alive.
Key Takeaway: The Similac lawsuit filing deadline in 2026 varies by state, ranging from 2 to 4 years, but the discovery rule may extend eligibility for families who recently learned about the NEC-formula connection.
Frequently Asked Questions
What is the Similac lawsuit about in 2026?
The Similac lawsuit in 2026 is a federal mass tort case against Abbott Laboratories alleging that its cow’s milk-based NICU formulas caused necrotizing enterocolitis in premature infants.
Thousands of families have filed individual claims consolidated under MDL No. 3026 in the Northern District of Illinois.
The litigation is in the bellwether trial and global settlement discussion phase as of 2026.
Who qualifies to file a Similac NEC lawsuit claim?
Families qualify if their premature infant was fed Similac or another cow’s milk-based NICU formula and was subsequently diagnosed with necrotizing enterocolitis.
Both personal injury claims (for surviving infants with NEC complications) and wrongful death claims (for infants who died from NEC) are available.
Medical records confirming prematurity, formula feeding, and NEC diagnosis are required to support the claim.
How much money can I get from the Similac lawsuit?
Estimated payouts range from $50,000 to over $10 million depending on the severity of the infant’s NEC injury.
Wrongful death cases and cases involving permanent injuries like short bowel syndrome typically produce the highest compensation amounts.
No confirmed global settlement fund has been announced as of early 2026, so final amounts are subject to ongoing litigation outcomes.
What is the filing deadline for the Similac lawsuit in 2026?
The filing deadline depends on the statute of limitations in the state where the infant was harmed, typically ranging from 2 to 4 years from the injury or discovery date.
Many states apply a “discovery rule” that may extend the deadline for families who only recently learned about the formula-NEC connection.
Families should speak with a mass tort attorney immediately to determine whether their specific claim is still within the filing window.
What is the difference between the Similac class action and the mass tort?
The Similac lawsuit is a mass tort, meaning each family files an individual claim evaluated on its own facts and injury severity. It is not a class action.
In a class action, all plaintiffs share one lawsuit and receive roughly equal, usually small payouts. In this mass tort MDL, payouts are tied to each child’s specific injuries.
This distinction means NEC claimants in severe cases can recover far more than they would in a traditional class action settlement.
Where This Leaves Families in 2026
The Similac lawsuit is real, active, and producing results for families who took action. The MDL in Illinois has generated verdicts that demonstrate juries take these claims seriously. Settlement talks are underway, and the litigation trajectory points toward broader resolution in the coming months.
If your premature baby was fed Similac or a similar formula in the NICU and developed NEC, your window to act may be narrower than you think.
Gather your child’s NICU and medical records. Reach out to a mass tort law firm that handles baby formula NEC cases. Do not let a deadline quietly pass before you know where you stand.
